Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Techcyte logo — The Anatomic & Clinical Pathology AI Platform

Techcyte

The Anatomic & Clinical Pathology AI Platform

Founded 2013 United States Orem, United States 128 employees Venture round Total: $35.40M AI, Analytics +6

General Information

Company Name Techcyte
Founded Year 2013
Location United States Orem, United States
Employees 128
Industries AI, Analytics, Big Data +5
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Techcyte. To contact Techcyte, visit techcyte.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Techcyte

Techcyte is a groundbreaking startup in the field of AI, Analytics, Biotechnology, and Health Care, founded in 2013. The company's slogan "The Anatomic & Clinical Pathology AI Platform" encapsulates its main focus: transforming the practice of pathology. They offer a unified pathology platform that digitalizes lab workflows and provides AI tools to enhance the efficiency and accuracy of diagnostic testing. In addition to revolutionizing pathology, Techcyte has a bold mission to positively impact the health of humans, animals, and the environment through the use of artificial intelligence. They have achieved this by partnering with leading labs, whole slide scanner manufacturers, AI vendors, diagnostic companies, hardware manufacturers, and solution providers to deliver a unified clinical and anatomic pathology platform to labs and clinics worldwide. The company is headquartered in the United States and their most recent milestone is a $8.40M Venture Round investment received on 22 December 2023. Although the specific investors for this round are not mentioned, this funding is poised to further strengthen Techcyte's position as a trailblazer in AI-driven pathology solutions.

Taxonomy: AI-based cellular digital diagnostics, Clinical Pathology AI Platform, Whole Slide Scanners, Digital Microscopy, Deep Learning Image Analysis, Diagnostic Testing, Veterinary Diagnostics, Environmental Clinics and Labs, Pathology Platforms, Diagnostic Companies, SaaS Provider, HIPAA Compliant

Services & Products

AI-assisted digital pathology and diagnostics solutions

Target Customers

Pathologists laboratory professionals healthcare institutions veterinary facilities

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $8.40M -
22 Dec 2023
Corporate Round $21.00M 2
ARUP Laboratories, Zoetis
19 Aug 2021
Series A $4.30M -
18 Jan 2018
Seed Round $1.70M -
01 Jan 2016

Techcyte Alternatives & Competitors

View All Alternatives
Techcyte vs
Ibex Medical Analytics
Ibex Medical Analytics United States

Pioneering AI-based cancer diagnostics in pathology

Series C
97 employees
AI, Analytics
Compare Techcyte vs Ibex Medical Analytics
Techcyte vs
Aiforia Technologies
Aiforia Technologies Finland

Translate images into data, discoveries, and diagnoses with deep learning AI for image analysis.

IPO
79 employees
AI, Biotechnology
Techcyte vs
Virasoft Corporation
Virasoft Corporation United States

Connecting People. Elevating Patient Care. Complete Pathology Workflows with Integrated Digital Path...

43 employees
AI, Biotechnology
View all alternatives

FAQ About Techcyte

The Anatomic & Clinical Pathology AI Platform
Techcyte was founded in 2013.
Techcyte is headquartered in Orem, United States.
Techcyte operates in AI, Analytics, Big Data, Biotechnology, Computer Vision, Health Care, SaaS and Machine Learning. Its work centres on AI-based cellular digital diagnostics, Clinical Pathology AI Platform, Whole Slide Scanners and Digital Microscopy. Its customers include Pathologists, laboratory professionals and healthcare institutions.
Techcyte has approximately 128 employees.
Techcyte has completed 4 funding rounds, raising a total of $35.40M. The latest funding stage is Venture round.
Techcyte offers: AI-assisted digital pathology and diagnostics solutions.
Top alternatives and competitors to Techcyte include Ibex Medical Analytics, Aiforia Technologies, Virasoft Corporation, Tribun Health, BioImagene. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Techcyte and Ibex Medical Analytics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Techcyte, https://bouncewatch.com/company/techcyte, updated 26 February 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes